Company Filing History:
9 out of 413 
5 out of 532 
2 out of 1,744 
Years Active: 2011-2024
Title: Inventor Spotlight: Xi Jason Jiang - Pioneering Innovations in Biomedical Technologies
Introduction: Xi Jason Jiang, a prolific inventor based in Cincinnati, OH, has made significant contributions to the field of biomedical research through his groundbreaking patents and inventions. With a keen focus on developing novel treatment methods and vaccine compositions, Jiang's work has garnered recognition for its potential impact on improving healthcare outcomes.
Latest Patents:
1. "Methods for treating subjects suffering from acute myeloid leukemia with FLT3 ligand-targeted miR-150 nanoparticles": Jiang's innovative nanoparticle delivery system offers a promising approach for treating acute myeloid leukemia by delivering microRNA-150 to FLT3-overexpressing AML cells. This method holds great potential for enhancing targeted therapy in cancer treatment.
2. "Norovirus S particle based vaccines and methods of making and using same": Jiang's work in developing polyvalent icosahedral compositions for antigen presentation through S particles made up of recombinant fusion proteins showcases his dedication to vaccine development. This patent highlights Jiang's commitment to advancing immunization strategies.
Career Highlights: Xi Jason Jiang has amassed an impressive portfolio of 13 patents, demonstrating his expertise in biomedical technologies. Notably, Jiang has worked with renowned institutions such as the Children's Hospital Medical Center and the University of Cincinnati, where he has played a pivotal role in driving innovation in healthcare.
Collaborations: Jiang has collaborated with esteemed colleagues in his research endeavors, including Ming Tan and Jianjun Chen. Together, they have contributed to pioneering projects that aim to address critical healthcare challenges and pave the way for transformative solutions in the field of biomedicine.
Conclusion: Xi Jason Jiang's inventive spirit and commitment to advancing biomedical technologies have established him as a leading figure in the industry. His latest patents underscore his dedication to developing innovative therapies and vaccine strategies that have the potential to revolutionize healthcare practices. Jiang's collaborative efforts with accomplished peers further exemplify his collaborative approach towards driving progress in biomedical research.